7mj9 - Revision history

OCA at 16:13, 18 October 2023

OCA — Wed, 18 Oct 2023 16:13:00 GMT

←Older revision		Revision as of 16:13, 18 October 2023
Line 1:		Line 1:

-	====	+	==HLA-A*02:01 bound to Neuroblastoma Derived mutant IGFBPL1 peptide==
-	<StructureSection load='7mj9' size='340' side='right'caption='[[7mj9]]' scene=''>	+	<StructureSection load='7mj9' size='340' side='right'caption='[[7mj9]], [[Resolution\|resolution]] 1.75Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[7mj9]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7MJ9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7MJ9 FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7mj9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7mj9 OCA], [https://pdbe.org/7mj9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7mj9 RCSB], [https://www.ebi.ac.uk/pdbsum/7mj9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7mj9 ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.75Å</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7mj9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7mj9 OCA], [https://pdbe.org/7mj9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7mj9 RCSB], [https://www.ebi.ac.uk/pdbsum/7mj9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7mj9 ProSAT]</span></td></tr>
	</table>		</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/A0A140T913_HUMAN A0A140T913_HUMAN]
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The majority of oncogenic drivers are intracellular proteins, thus constraining their immunotherapeutic targeting to mutated peptides (neoantigens) presented by individual human leukocyte antigen (HLA) allotypes(1). However, most cancers have a modest mutational burden that is insufficient to generate responses using neoantigen-based therapies(2,3). Neuroblastoma is a paediatric cancer that harbours few mutations and is instead driven by epigenetically deregulated transcriptional networks(4). Here we show that the neuroblastoma immunopeptidome is enriched with peptides derived from proteins that are essential for tumourigenesis and focus on targeting the unmutated peptide QYNPIRTTF, discovered on HLA-A24:02, which is derived from the neuroblastoma dependency gene and master transcriptional regulator PHOX2B. To target QYNPIRTTF, we developed peptide-centric chimeric antigen receptors (CARs) using a counter-panning strategy with predicted potentially cross-reactive peptides. We further hypothesized that peptide-centric CARs could recognize peptides on additional HLA allotypes when presented in a similar manner. Informed by computational modelling, we showed that PHOX2B peptide-centric CARs also recognize QYNPIRTTF presented by HLA-A23:01 and the highly divergent HLA-B*14:02. Finally, we demonstrated potent and specific killing of neuroblastoma cells expressing these HLAs in vitro and complete tumour regression in mice. These data suggest that peptide-centric CARs have the potential to vastly expand the pool of immunotherapeutic targets to include non-immunogenic intracellular oncoproteins and widen the population of patients who would benefit from such therapy by breaking conventional HLA restriction.
		+
		+	Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.,Yarmarkovich M, Marshall QF, Warrington JM, Premaratne R, Farrel A, Groff D, Li W, di Marco M, Runbeck E, Truong H, Toor JS, Tripathi S, Nguyen S, Shen H, Noel T, Church NL, Weiner A, Kendsersky N, Martinez D, Weisberg R, Christie M, Eisenlohr L, Bosse KR, Dimitrov DS, Stevanovic S, Sgourakis NG, Kiefel BR, Maris JM Nature. 2021 Nov;599(7885):477-484. doi: 10.1038/s41586-021-04061-6. Epub 2021 , Nov 3. PMID:34732890<ref>PMID:34732890</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 7mj9" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Beta-2 microglobulin 3D structures\|Beta-2 microglobulin 3D structures]]
		+	*[[MHC 3D structures\|MHC 3D structures]]
		+	*[[MHC I 3D structures\|MHC I 3D structures]]
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Z-disk~~]]	+	[[Category: Maris JM]]
		+	[[Category: Sgourakis NG]]
		+	[[Category: Toor JS]]
		+	[[Category: Tripathi SM]]
		+	[[Category: Truong HV]]
		+	[[Category: Yarmarkovich M]]

OCA at 06:08, 18 August 2021

OCA — Wed, 18 Aug 2021 06:08:26 GMT

←Older revision		Revision as of 06:08, 18 August 2021
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 7mj9 ~~is ON HOLD until Paper Publication~~	+	====
-		+	<StructureSection load='7mj9' size='340' side='right'caption='[[7mj9]]' scene=''>
-	~~Authors~~: ~~Toor, J~~.S.~~, Tripathi, S~~.M.~~, Truong, H~~.V.~~, Yarmarkovich, M~~.~~, Maris, J~~.M., ~~Sgourakis, N~~.G.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>
-	~~Description: HLA~~-~~A*02:01 bound to Neuroblastoma Derived mutant IGFBPL1 peptide~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7mj9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7mj9 OCA], [https://pdbe.org/7mj9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7mj9 RCSB], [https://www.ebi.ac.uk/pdbsum/7mj9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7mj9 ProSAT]</span></td></tr>
-	[~~[Category~~: ~~Unreleased Structures~~]]	+	</table>
-	~~[[Category: Yarmarkovich~~, ~~M]]~~	+	__TOC__
-	[~~[Category~~: ~~Truong, H~~.V]]	+	</StructureSection>
-	[~~[Category~~: ~~Maris, J~~.M]]	+	[[Category: Large Structures]]
-	[~~[Category~~: ~~Tripathi, S~~.M]]	+	[[Category: Z-disk]]
-	[[Category: ~~Toor, J.S~~]]	+
-	[[Category: ~~Sgourakis, N.G~~]]	+

OCA at 11:04, 9 June 2021

OCA — Wed, 09 Jun 2021 11:04:10 GMT

←Older revision		Revision as of 11:04, 9 June 2021
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 7mj9 is ON HOLD	+	The entry 7mj9 is ON HOLD until Paper Publication

	Authors: Toor, J.S., Tripathi, S.M., Truong, H.V., Yarmarkovich, M., Maris, J.M., Sgourakis, N.G.		Authors: Toor, J.S., Tripathi, S.M., Truong, H.V., Yarmarkovich, M., Maris, J.M., Sgourakis, N.G.

OCA: Protected "7mj9" [edit=sysop:move=sysop]

OCA — Wed, 28 Apr 2021 04:20:26 GMT

Protected "7mj9" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:20, 28 April 2021

OCA: New page: '''Unreleased structure''' The entry 7mj9 is ON HOLD Authors: Toor, J.S., Tripathi, S.M., Truong, H.V., Yarmarkovich, M., Maris, J.M., Sgourakis, N.G. Description: HLA-A*02:01 bound to...

OCA — Wed, 28 Apr 2021 04:20:25 GMT

New page: '''Unreleased structure''' The entry 7mj9 is ON HOLD Authors: Toor, J.S., Tripathi, S.M., Truong, H.V., Yarmarkovich, M., Maris, J.M., Sgourakis, N.G. Description: HLA-A*02:01 bound to...

New page

'''Unreleased structure'''

The entry 7mj9 is ON HOLD

Authors: Toor, J.S., Tripathi, S.M., Truong, H.V., Yarmarkovich, M., Maris, J.M., Sgourakis, N.G.

Description: HLA-A*02:01 bound to Neuroblastoma Derived mutant IGFBPL1 peptide
[[Category: Unreleased Structures]]
[[Category: Yarmarkovich, M]]
[[Category: Truong, H.V]]
[[Category: Maris, J.M]]
[[Category: Tripathi, S.M]]
[[Category: Toor, J.S]]
[[Category: Sgourakis, N.G]]